Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
PACTR201311000700893Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of aspirin + atorvastatin + hydrochlorothiazide + enalapril in pregnancy-induced hypertension (PIH) and preeclampsia (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Pregnancy-induced hypertension. Planned start Oct 2015; status: not yet recruiting.
02
Drugs
aspirin + atorvastatin + hydrochlorothiazide + enalapril
03
Conditions
pregnancy-induced hypertension (PIH)preeclampsia
Beyond the preview
Go deeper on PACTR201311000700893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201311000700893.